2017 Fiscal Year Final Research Report
Development of small compounds that induce alternative autophagy
| Project/Area Number |
16K15230
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Pathological medical chemistry
|
|---|
| Research Institution | Tokyo Medical and Dental University |
|---|
Principal Investigator |
SHIMIZU Shigeomi 東京医科歯科大学, 難治疾患研究所, 教授 (70271020)
|
|---|
| Project Period (FY) |
2016-04-01 – 2018-03-31
|
| Keywords | ケミカルバイオロジー / オートファジー / 実験病理学 |
|---|
| Outline of Final Research Achievements |
Autophagy is a cellular function that degrades subcellular constituents to contribute cellular homeostasis. The defect of alternative autophagy (Atg5-independent autophagy) may cause various diseases, such as anemia, neurodegenerative diseases, dermatitis, and colitis. In this study, we aimed to identify small chemical compounds/natural compounds that activate alternative autophagy and improve various diseases. As a result, we identified three anti-cancer compounds, two anti-polyglutamine disease compounds, and two anti-tauopathy compounds. We also identified two anti-fatty liver natural compounds.
|
| Free Research Field |
細胞生物学
|
